Search Results

Methylnaltrexone bromide gets things moving in constipation

Source: Inpharma, Volume 1, Number 1667, 2008-12-06 , pp. 17-17(1)

Publisher: Adis International

Methylnaltrexone bromide approved for opioid-induced constipation in EU.

Source: Inpharma, Volume 1, Number 1646, 2008-07-12 , pp. 18-18(1)

Publisher: Adis International

Oral methylnaltrexone is an effective treatment for opioid-induced constipation

Source: Inpharma, Volume 1, Number 1640, 2008-05-31 , pp. 14-14(1)

Publisher: Adis International

Methylnaltrexone approved for OIC in Canada.

Source: Inpharma, Volume 1, Number 1633, 2008-04-12 , pp. 23-23(1)

Publisher: Adis International

PRO 140, an HIV-1 entry inhibitor, has shown potential for the treatment of patients with HIV infection

Source: Inpharma, Volume 1, Number 1586, 2007-05-05 , pp. 8-8(1)

Publisher: Adis International

Methylnaltrexone: positive results in opiate-induced constipation

Source: Inpharma, Volume 1, Number 1506, 2005-09-24 , pp. 20-20(1)

Publisher: Adis International

Methylnaltrexone: positive results in opiate-induced constipation

Source: Reactions, Volume 1, Number 1070, 2005-09-24 , pp. 3-3(1)

Publisher: Adis International

The peripheral opioid receptor antagonist methylnaltrexone alleviates opioid-induced constipation

Source: Inpharma, Volume 1, Number 1479, 2005-03-19 , pp. 7-7(1)

Publisher: Adis International

The peripheral opioid receptor antagonist methylnaltrexone alleviates opioid-induced constipation

Source: Reactions, Volume 1, Numbers 1044-1045, 2005-03-26 , pp. 4-4(1)

Publisher: Adis International

Methylnaltrexone improves the time to GI recovery following segmental colectomy

Source: Inpharma, Volume 1, Number 1472, 2005-01-29 , pp. 6-6(1)

Publisher: Adis International

IV methylnaltrexone effectively treated opioid-induced urinary retention in a phase II clinical trial

Source: Inpharma, Volume 1, Number 1409, 2003 , pp. 9-9(1)

Publisher: Adis International